(Q73128626)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

R Pakala

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C T Liang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C R Benedict

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

89-96

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

A perspective of coronary disease seen through the arteries of living man

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Regulation of thrombin generation and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Thrombin-cellular interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

PAR3 is a cofactor for PAR4 activation by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

How the protease thrombin talks to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Characterization of a functional thrombin receptor. Issues and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Minimal sequence requirement of thrombin receptor agonist peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Involvement of the "tethered-ligand" receptor in thrombin inhibition of platelet adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

New Variant of Human Tissue Plasminogen Activator (TPA) With Enhanced Efficacy and Lower Incidence of Bleeding Compared With Recombinant Human TPA

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Pharmacologic Aspects of the Development of Selective Synthetic Thrombin Inhibitors as Anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Role of thrombin and thromboxane A2 in reocclusion following coronary thrombolysis with tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

A pilot, early angiographic patency study using a direct thrombin inhibitor as adjunctive therapy to streptokinase in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

Thrombin receptors on human platelets. Initial localization and subsequent redistribution during platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900307-8

7 January 2021

10.1016/S0049-3848(00)00307-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11053621%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference